Clinical Trial Update: Safety and Efficacy Study of Peripheral Blood Mononucleated Cells for Treatment of Liver Cirrhosis [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the safety and efficacy of autologous peripheral blood mononucleated cells for treating liver cirrhosis, with results posted after …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Peripheral Blood Mononucleated Cells (peripheral blood mononucleated cells)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Liver Cirrhosis | Phase 1 | Status: COMPLETED | Results posted: 2014-12-19